Global IVIG Competitive Landscape Professional Research Report 2024

Global IVIG Competitive Landscape Professional Research Report 2024

Research Summary

Intravenous immunoglobulin (IVIG) is a medical treatment that involves the intravenous infusion of concentrated immunoglobulins, which are antibodies derived from pooled plasma of thousands of blood donors. Immunoglobulins are proteins that play a key role in the immune system＇s defense against infections. IVIG is used as a therapeutic intervention in various medical conditions, including autoimmune disorders, primary immunodeficiencies, and certain neurological conditions. The infusion of IVIG provides a boost to the immune system, helping to modulate and regulate immune responses. It is often prescribed to individuals with compromised immune function or those experiencing abnormal immune activity. IVIG therapy is administered in a clinical setting, and the dosage and frequency of infusions depend on the specific medical condition being treated. The use of IVIG has shown efficacy in managing a range of immune-related disorders, making it a valuable tool in medical practice.

According to DIResearch's in-depth investigation and research, the global IVIG market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of IVIG include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of IVIG. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global IVIG market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the IVIG market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of IVIG industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of IVIG Include:

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

IVIG Product Segment Include:

IVIg Liquid

IVIg Powder

IVIG Product Application Include:

Immunodeficiency

Autoimmune Disease

Acute Infection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global IVIG Industry PESTEL Analysis

Chapter 3: Global IVIG Industry Porter’s Five Forces Analysis

Chapter 4: Global IVIG Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global IVIG Market Size and Forecast by Type and Application Analysis

Chapter 6: North America IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa IVIG Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global IVIG Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources